Anti-MOG antibodies are under polygenic regulation with the most significant control coming from the C-type lectin-like gene locus

Genes and Immunity

Volumn 14, Issue 7, 2013, Pages 409-419

  Flytzani, S ^a   Stridh, P ^a   Guerreiro Cacais, A O ^a   Marta, M ^a   Hedreul, M T ^a   Jagodic, M ^a   Olsson, T ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

Author keywords

anti MOG antibodies; APLEC; EAE MS; gene regulation; myelin oligodendrocyte glycoprotein

Indexed keywords

ANTIBODY; CD3 ANTIGEN; CD4 ANTIGEN; IMMUNOGLOBULIN G1; IMMUNOGLOBULIN G2B; LECTIN; MYELIN OLIGODENDROCYTE GLYCOPROTEIN;

ALLERGIC ENCEPHALOMYELITIS; AMIG3 GENE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY RESPONSE; ARTICLE; B LYMPHOCYTE; CHROMOSOME 4; CONTROLLED STUDY; DCAR1 GENE; DCIR1 GENE; DCIR2 GENE; DCIR3 GENE; DCIR4 GENE; FEMALE; GENE; GENE CONTROL; GENE MAPPING; GENETIC RISK; HUMORAL IMMUNITY; MALE; MCL GENE; MINCLE GENE; MULTIPLE SCLEROSIS; NONHUMAN; PRIORITY JOURNAL; QUANTITATIVE TRAIT LOCUS; RAT; RECEPTOR GENE; TH2 CELL;

ANIMALIA; RATTUS;

ANIMALS; B-LYMPHOCYTES; CHROMOSOME MAPPING; ENCEPHALOMYELITIS, AUTOIMMUNE, EXPERIMENTAL; IMMUNOGLOBULIN G; LECTINS, C-TYPE; MULTIFACTORIAL INHERITANCE; MYELIN-OLIGODENDROCYTE GLYCOPROTEIN; QUANTITATIVE TRAIT LOCI; RATS; RATS, INBRED STRAINS; TH2 CELLS;

EID: 84886726447     PISSN: 14664879     EISSN: 14765470     Source Type: Journal    
DOI: 10.1038/gene.2013.33     Document Type: Article

References (49)

1. Obermeier B, Mentele R, Malotka J, Kellermann J, Kumpfel T, Wekerle H et al. Matching of oligoclonal immunoglobulin transcriptomes and proteomes of cerebrospinal fluid in multiple sclerosis. Nat Med 2008; 14: 688-693.
2. Serafini B, Rosicarelli B, Magliozzi R, Stigliano E, Aloisi F. Detection of ectopic B-cell follicles with germinal centers in the meninges of patients with secondary progressive multiple sclerosis. Brain Pathol 2004; 14: 164-174.
3. Hauser SL, Waubant E, Arnold DL, Vollmer T, Antel J, Fox RJ et al. B-cell depletion with rituximab in relapsing-remitting multiple sclerosis. N Engl J Med 2008; 358: 676-688.
4. Genain C, Cannella B, Hauser S, Raine C. Identification of autoantibodies associated with myelin damage in multiple sclerosis. Nat Med 1999; 5: 170-175.
5. Reindl M, Linington C, Brehm U, Egg R, Dilitz E, Deisenhammer F et al. Antibodies against the myelin oligodendrocyte glycoprotein and the myelin basic protein in multiple sclerosis and other neurological diseases: A comparative study. Brain 1999; 122: 2047-2056.
6. Zhou D, Srivastava R, Nessler S, Grummel V, Sommer N, Bruck W et al. Identification of a pathogenic antibody response to native myelin oligodendrocyte glycoprotein in multiple sclerosis. Proc Natl Acad Sci USA 2006; 103: 19057-19062.
7. Olsson T. White matter disease: Roles of anti-MOG antibodies in demyelinating diseases. Nat Rev Neurol 2011; 7: 248-249.
8. Jagodic M, Colacios C, Nohra R, Dejean AS, Beyeen AD, Khademi M et al. A role for VAV1 in experimental autoimmune encephalomyelitis and multiple sclerosis. Sci Transl Med 2009; 1: 10ra21.
9. Swanberg M, Lidman O, Padyukov L, Eriksson P, Akesson E, Jagodic M et al. MHC2TA is associated with differential MHC molecule expression and susceptibility to rheumatoid arthritis, multiple sclerosis and myocardial infarction. Nat Genet 2005; 37: 486-494.
10. Olofsson P, Holmberg J, Tordsson J, Lu S, Akerstrom B, Holmdahl R. Positional identification of Ncf1 as a gene that regulates arthritis severity in rats. Nat Genet 2003; 33: 25-32.
11. Wicker LS, Clark J, Fraser HI, Garner VE, Gonzalez-Munoz A, Healy B et al. Type 1 diabetes genes and pathways shared by humans and NOD mice. J Autoimmun 2005; 25: 29-33.
12. Schluesener H, Sobel R, Linington C, Weiner H. A monoclonal antibody against a myelin oligodendrocyte glycoprotein induces relapses and demyelination in central nervous system autoimmune disease. J Immunol 1987; 139: 4016-4037.
13. Linington C, Bradl M, Lassmann H, Brunner C, Vass K. Augmentation of demyelination in rat acute allergic encephalomyelitis by circulating mouse monoclonal antibodies directed against a myelin/oligodendrocyte glycoprotein. Am J Pathol 1988; 130: 443-497.
14. Genain C, Nguyen M, Letvin N, Pearl R, Davis R, Adelman M et al. Antibody facilitation of multiple sclerosis-like lesions in a nonhuman primate. J Clin Invest 1995; 96: 2966-3040.
15. Thessen Hedreul M, Gillett A, Olsson T, Jagodic M, Harris R. Characterization of multiple sclerosis candidate gene expression kinetics in rat experimental autoimmune encephalomyelitis. J Neuroimmunol 2009; 210: 30-39.
16. Weissert R, Wallstrom E, Storch MK, Stefferl A, Lorentzen J, Lassmann H et al. MHC haplotype-dependent regulation of MOG-induced EAE in rats. J Clin Invest 1998; 102: 1265-1273.
17. Dahlman I, Lorentzen JC, de Graaf KL, Stefferl A, Linington C, Luthman H et al. Quantitative trait loci disposing for both experimental arthritis and encephalomyelitis in the DA rat; impact on severity of myelin oligodendrocyte glycoproteininduced experimental autoimmune encephalomyelitis and antibody isotype pattern. Eur J Immunol 1998; 28: 2188-2196.
18. Marta M, Stridh P, Becanovic K, Gillett A, Ockinger J, Lorentzen J et al. Multiple loci comprising immune-related genes regulate experimental neuroinflammation. Genes Immun 2010; 11: 21-57.
19. Lorentzen J, Flornes L, Eklöw C, Ba?ckdahl L, Ribbhammar U, Guo J et al. Association of arthritis with a gene complex encoding C-type lectin-like receptors. Arthritis Rheum 2007; 56: 2620-2652.
20. Ribbhammar U, Flornes L, Backdahl L, Luthman H, Fossum S, Lorentzen JC. High resolution mapping of an arthritis susceptibility locus on rat chromosome 4, and characterization of regulated phenotypes. Hum Mol Genet 2003; 12: 2087-2096.
21. Amor S, Groome N, Linington C, Morris MM, Dornmair K, Gardinier MV et al. Identification of epitopes of myelin oligodendrocyte glycoprotein for the induction of experimental allergic encephalomyelitis in SJL and Biozzi AB/H mice. J Immunol 1994; 153: 4349-4356.
22. Storch MK, Stefferl A, Brehm U, Weissert R, Wallstrom E, Kerschensteiner M et al. Autoimmunity to myelin oligodendrocyte glycoprotein in rats mimics the spectrum of multiple sclerosis pathology. Brain Pathol 1998; 8: 681-694.
23. Broman KW, Wu H, Sen S, Churchill GA. R/qtl: QTL mapping in experimental crosses. Bioinformatics 2003; 19: 889-890.
24. Haley CS, Knott SA. A simple regression method for mapping quantitative trait loci in line crosses using flanking markers. Heredity 1992; 69: 315-324.
25. Churchill GA, Doerge RW. Empirical threshold values for quantitative trait mapping. Genetics 1994; 138: 963-971.
26. Flornes L, Bryceson Y, Spurkland A, Lorentzen J, Dissen E, Fossum S. Identification of lectin-like receptors expressed by antigen presenting cells and neutrophils and their mapping to a novel gene complex. Immunogenetics 2004; 56: 506-523.
27. Griffiths MM, Wang J, Joe B, Dracheva S, Kawahito Y, Shepard JS et al. Identification of four new quantitative trait loci regulating arthritis severity and one new quantitative trait locus regulating autoantibody production in rats with collageninduced arthritis. Arthritis Rheum 2000; 43: 1278-1289.
28. Nordquist N, Olofsson P, Vingsbo-Lundberg C, Petterson U, Holmdahl R. Complex genetic control in a rat model for rheumatoid arthritis. J Autoimmun 2000; 15: 425-432.
29. Jagodic M, Marta M, Becanovic K, Sheng J, Nohra R, Olsson T et al. Resolution of a 16.8-Mb autoimmunity-regulating rat chromosome 4 region into multiple encephalomyelitis quantitative trait loci and evidence for epistasis. J Immunol 2005; 174: 918-942.
30. Mordes JP, Cort L, Norowski E, Leif J, Fuller JM, Lernmark A et al. Analysis of the rat Iddm14 diabetes susceptibility locus in multiple rat strains: Identification of a susceptibility haplotype in the Tcrb-V locus. Mamm Genome 2009; 20: 162-169.
31. Dahlman I, Lorentzen J, de Graaf K, Stefferl A, Linington C, Luthman H et al. Quantitative trait loci disposing for both experimental arthritis and encephalomyelitis in the DA rat; impact on severity of myelin oligodendrocyte glycoprotein-induced experimental autoimmune encephalomyelitis and antibody isotype pattern. Eur J Immunol 1998; 28: 2188-2284.
32. Furuya T, Salstrom JL, McCall-Vining S, Cannon GW, Joe B, Remmers EF et al. Genetic dissection of a rat model for rheumatoid arthritis: Significant gender influences on autosomal modifier loci. Hum Mol Genet 2000; 9: 2241-2250.
33. Darvasi A, Soller M. Advanced intercross lines, an experimental population for fine genetic mapping. Genetics 1995; 141: 1199-1406.
34. Rintisch C, Kelkka T, Norin U, Lorentzen J, Olofsson P, Holmdahl R. Finemapping of the arthritis QTL Pia7 reveals co-localization with Oia2 and the APLEC locus. Genes Immun 2010; 11: 239-284.
35. Gracie J, Bradley J. Interleukin-12 induces interferon-gamma-dependent switching of IgG alloantibody subclass. Eur J Immunol 1996; 26: 1217-1238.
36. Kanazawa N, Tashiro K, Inaba K, Miyachi Y. Dendritic cell immunoactivating receptor, a novel C-type lectin immunoreceptor, acts as an activating receptor through association with Fc receptor gamma chain. J Biol Chem 2003; 278: 32645-32697.
37. Kanazawa N, Okazaki T, Nishimura H, Tashiro K, Inaba K, Miyachi Y. DCIR acts as an inhibitory receptor depending on its immunoreceptor tyrosine-based inhibitory motif. J Invest Dermatol 2002; 118: 261-267.
38. Fujikado N, Saijo S, Yonezawa T, Shimamori K, Ishii A, Sugai S et al. Dcir deficiency causes development of autoimmune diseases in mice due to excess expansion of dendritic cells. Nat Med 2008; 14: 176-180.
39. Lyons J-A, Ramsbottom M, Cross A. Critical role of antigen-specific antibody in experimental autoimmune encephalomyelitis induced by recombinant myelin oligodendrocyte glycoprotein. Eur J Immunol 2002; 32: 1905-1918.
40. Elliott C, Lindner M, Arthur A, Brennan K, Jarius S, Hussey J et al. Functional identification of pathogenic autoantibody responses in patients with multiple sclerosis. Brain 2012; 135: 1819-1833.
41. Müssener A, Lorentzen J, Kleinau S, Klareskog L. Altered Th1/Th2 balance associated with non-major histocompatibility complex genes in collageninduced arthritis in resistant and non-resistant rat strains. Eur J Immunol 1997; 27: 695-704.
42. Olsson T. Critical influences of the cytokine orchestration on the outcome of myelin antigen-specific T-cell autoimmunity in experimental autoimmune encephalomyelitis and multiple sclerosis. Immunol Rev 1995; 144: 245-268.
43. Willcocks LC, Smith KG, Clatworthy MR. Low-affinity Fc gamma receptors, autoimmunity and infection. Expert Rev Mol Med 2009; 11: E24.
44. Nimmerjahn F, Bruhns P, Horiuchi K, Ravetch JV. FcgammaRIV: A novel FcR with distinct IgG subclass specificity. Immunity 2005; 23: 41-51.
45. Baudino L, Azeredo da Silveira S, Nakata M, Izui S. Molecular and cellular basis for pathogenicity of autoantibodies: Lessons from murine monoclonal autoantibodies. Springer Semin Immunopathol 2006; 28: 175-184.
46. Takahashi S, Fossati L, Iwamoto M, Merino R, Motta R, Kobayakawa T et al. Imbalance towards Th1 predominance is associated with acceleration of lupuslike autoimmune syndrome in MRL mice. J Clin Invest 1996; 97: 1597-1604.
47. Peng SL, Szabo SJ, Glimcher LH. T-bet regulates IgG class switching and pathogenic autoantibody production. Proc Natl Acad Sci USA 2002; 99: 5545-5550.
48. Genain CP, Abel K, Belmar N, Villinger F, Rosenberg DP, Linington C et al. Late complications of immune deviation therapy in a nonhuman primate. Science 1996; 274: 2054-2057.
49. McFarland HF. Complexities in the treatment of autoimmune disease. Science 1996; 274: 2037-2038.